Methylphenidate Hydrochloride
Product Images NDC 54868-6262

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 54868-6262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (18 mg Tablet Bottle Label)

Methylphenidate Hydrochloride 18 mg extended-release tablets carton label from Physicians Total Care, Inc. The label specifies each tablet contains 18 mg methylphenidate HCl and a total of 30 tablets per package. Additional information includes storage instructions, warnings about dispensing, and lot and expiration details.*

FDA Label Image

Principal Display Panel (27 mg Tablet Bottle Label)

Methylphenidate Hydrochloride 27 mg tablet blister pack label from Physicians Total Care, Inc. The label includes dosage strength, total of 30 tablets per package, a drug identification number (NDC), and cautionary text about federal prescription regulations and storage instructions. The label also features barcodes and lot and expiration information.*

FDA Label Image

Chemical Structure (Methylphenidate 01)

Chemical structure of Methylphenidate Hydrochloride, showing its molecular arrangement including a phenyl ring, methyl ester group, piperidine ring, and hydrochloride component.*

FDA Label Image

Figure 1 (Methylphenidate 02)

A pharmacokinetic curve displaying mean plasma methylphenidate HCl concentration (ng/mL) over time (hours). The graph compares extended-release tablets (18 mg once daily) with a 5 mg methylphenidate immediate-release tablet, illustrating concentration changes up to 30 hours.*

FDA Label Image

Figure 2 (Methylphenidate 03)

A bar graph displaying inattention/overactivity scale scores for Methylphenidate HCl extended-release tablets versus placebo across three studies. The vertical axis ranges from 0 to 16, indicating maximum symptoms, with black bars for Methylphenidate HCl and white bars for placebo, showing symptom levels in each study group.*

FDA Label Image

Figure 3 (Methylphenidate 04)

A line graph comparing the effects of Methylphenidate Hydrochloride Extended-Release Tablets once daily versus placebo over 12 hours post initial dose. The y-axis shows combined alertness scores, and the x-axis represents time in hours. The graph includes error bars and annotations indicating sample sizes at various time points.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.